We are live on
!
Find out more
AWA
Acumen Wealth Advisors Portfolio holdings
AUM
$472M
This Fund
S&P 500
This Quarter
Est. Return
+21.85%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$472M
AUM Growth
+$100M
(+27%)
Cap. Flow
+$47M
Cap. Flow
% of AUM
9.96%
Top 10 Holdings %
Top 10 Hldgs %
42.62%
Holding
534
New
92
Increased
119
Reduced
142
Closed
41
Avg Time Held
1.5
quarters
Top 10 Avg Time Held
0.8
quarters
Top 20 Avg Time Held
1.1
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Eagle Overseas Equity ETF
FEOE
|
+$21.7M |
| 2 |
Avantis US Small Cap Value ETF
AVUV
|
+$19.2M |
| 3 |
Avantis All International Markets Equity ETF
AVNM
|
+$14.6M |
| 4 |
NVIDIA
NVDA
|
+$14.3M |
| 5 |
Fidelity Fundamental Small-Mid Cap ETF
FFSM
|
+$14.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$31M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$11.6M |
| 3 |
iShares Core S&P Small-Cap ETF
IJR
|
+$10.3M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$4.5M |
| 5 |
Texas Instruments
TXN
|
+$4.37M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.79% |
| 2 | Technology | 26.27% |
| 3 | Financials | 6.06% |
| 4 | Healthcare | 5.69% |
| 5 | Consumer Discretionary | 5.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
JPMorgan Chase
JPM
$885B
| $4.85M | 1.03% |
14,821
+7,648
| +107% | +$2.38M |
2025 Q4
2 quarters
|
|
27
Eli Lilly
LLY
$1.05T
| $4.79M | 1.02% |
3,994
-372
| -9% | -$380K |
2025 Q4
2 quarters
|
|
28
Visa
V
$724B
| $4.72M | 1% |
13,764
-3,703
| -21% | -$1.19M |
2025 Q4
2 quarters
|
|
|
29
Berkshire Hathaway Class B
BRK.B
$1.1T
| $4.29M | 0.91% |
8,566
-9,364
| -52% | -$4.5M |
2025 Q4
2 quarters
|
|
30
GE Vernova
GEV
$268B
| $4.17M | 0.88% |
3,550
+2,249
| +173% | +$2.3M |
2025 Q4
2 quarters
|
|
31
US Bancorp
USB
$88.9B
| $3.93M | 0.83% |
64,487
-29,085
| -31% | -$1.63M |
2025 Q4
2 quarters
|
|
32
ASML
ASML
$684B
| $3.82M | 0.81% |
1,918
+1,215
| +173% | +$1.93M |
2025 Q4
2 quarters
|
|
33
Arista Networks
ANET
$273B
| $3.44M | 0.73% |
20,278
+13,159
| +185% | +$2.07M |
2025 Q4
2 quarters
|
|
34
Coca-Cola
KO
$379B
| $3.36M | 0.71% |
41,126
-7,779
| -16% | -$614K |
2025 Q4
2 quarters
|
|
35
Hilton Worldwide
HLT
$73.5B
| $3.35M | 0.71% |
10,145
-1,710
| -14% | -$562K |
2025 Q4
2 quarters
|
|
36
Eaton
ETN
$167B
| $3.28M | 0.7% |
7,696
+4,621
| +150% | +$1.86M |
2025 Q4
2 quarters
|
|
37
Vertiv
VRT
$93.5B
| $3.27M | 0.69% |
9,766
+6,289
| +181% | +$1.99M |
2025 Q4
2 quarters
|
|
38
RTX Corp
RTX
$251B
| $3.18M | 0.67% |
+16,780
| New | +$3.08M |
2026 Q2
0 quarters
|
|
39
TJX Companies
TJX
$153B
| $3.02M | 0.64% |
19,925
-2,325
| -10% | -$368K |
2025 Q4
2 quarters
|
|
40
Citigroup
C
$217B
| $2.89M | 0.61% |
20,629
+11,383
| +123% | +$1.48M |
2025 Q4
2 quarters
|
|
41
Blackrock
BLK
$168B
| $2.83M | 0.6% |
2,943
+1,842
| +167% | +$1.91M |
2025 Q4
2 quarters
|
|
42
Quest Diagnostics
DGX
$25.5B
| $2.75M | 0.58% |
12,998
+494
| +4% | +$97K |
2025 Q4
2 quarters
|
|
43
Amphenol
APH
$215B
| $2.73M | 0.58% |
30,910
+20,366
| +193% | +$1.47M |
2026 Q1
1 quarter
|
|
44
Parker-Hannifin
PH
$121B
| $2.58M | 0.55% |
2,636
+1,531
| +139% | +$1.4M |
2025 Q4
2 quarters
|
|
45
Thermo Fisher Scientific
TMO
$243B
| $2.49M | 0.53% |
4,956
-7,606
| -61% | -$3.65M |
2025 Q4
2 quarters
|
|
46
Wells Fargo
WFC
$253B
| $2.48M | 0.53% |
30,070
+17,327
| +136% | +$1.39M |
2025 Q4
2 quarters
|
|
47
Walmart Inc
WMT
$883B
| $2.47M | 0.52% |
21,818
+11,389
| +109% | +$1.41M |
2025 Q4
2 quarters
|
|
48
AbbVie
ABBV
$489B
| $2.44M | 0.52% |
9,708
+5,487
| +130% | +$1.18M |
2025 Q4
2 quarters
|
|
49
Targa Resources
TRGP
$61.5B
| $2.41M | 0.51% |
8,977
+5,666
| +171% | +$1.46M |
2025 Q4
2 quarters
|
|
50
Intuitive Surgical
ISRG
$150B
| $2.24M | 0.47% |
5,621
-1,195
| -18% | -$522K |
2025 Q4
2 quarters
|
|
Similar funds
LSA
CAP
ACM
SWRP
PC
PWM
WCM
CHIA
Acumen Wealth Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Acumen Wealth Advisors held 534 positions worth $472M, up 27% from $372M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Acumen Wealth Advisors deployed $47M of net new capital in Q2 2026, opening 92 new positions and adding to 119 existing holdings. Its largest new stake was Fidelity Fundamental Small-Mid Cap ETF: 397,385 shares worth $15.2M.
By sector, the portfolio is most concentrated in Miscellaneous at 39% of assets, up from 36% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $31M trimmed.
- Acumen Wealth Advisors's largest Q2 2026 buy was Fidelity Fundamental Small-Mid Cap ETF: 397,385 shares worth $15.2M.
- Acumen Wealth Advisors added most to First Eagle Overseas Equity ETF in Q2 2026, an estimated $21.7M increase.
- Acumen Wealth Advisors's biggest Q2 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $31M.
- Acumen Wealth Advisors fully exited Akre Focus ETF in Q2 2026, selling an estimated $45.5K.
- Acumen Wealth Advisors's ten largest holdings make up 43% of its $472M portfolio in Q2 2026.
- Acumen Wealth Advisors opened 92 new positions and closed 41 in Q2 2026.
- Acumen Wealth Advisors's portfolio value rose 27% quarter-over-quarter to $472M.
Based on Acumen Wealth Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.